Syra Health Corp.
SYRA
$0.10
-$0.0069-6.46%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.09M | 7.98M | 7.74M | 7.07M | 6.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.09M | 7.98M | 7.74M | 7.07M | 6.08M |
| Cost of Revenue | 6.02M | 6.21M | 5.84M | 5.28M | 4.51M |
| Gross Profit | 2.06M | 1.77M | 1.90M | 1.79M | 1.56M |
| SG&A Expenses | 4.46M | 4.89M | 5.25M | 5.10M | 4.55M |
| Depreciation & Amortization | 57.00K | 62.70K | 67.80K | 54.70K | 49.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.88M | 11.75M | 11.99M | 11.23M | 9.64M |
| Operating Income | -2.79M | -3.77M | -4.25M | -4.16M | -3.56M |
| Income Before Tax | -2.78M | -3.76M | -4.25M | -4.19M | -3.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.78 | -3.76 | -4.25 | -4.19 | -3.60 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.78M | -3.76M | -4.25M | -4.19M | -3.60M |
| EBIT | -2.79M | -3.77M | -4.25M | -4.16M | -3.56M |
| EBITDA | -2.74M | -3.70M | -4.18M | -4.11M | -3.51M |
| EPS Basic | -0.36 | -0.54 | -0.65 | -0.67 | -0.64 |
| Normalized Basic EPS | -0.23 | -0.34 | -0.40 | -0.42 | -0.40 |
| EPS Diluted | -0.36 | -0.54 | -0.65 | -0.67 | -0.64 |
| Normalized Diluted EPS | -0.23 | -0.34 | -0.40 | -0.42 | -0.40 |
| Average Basic Shares Outstanding | 35.29M | 30.20M | 26.73M | 23.83M | 21.61M |
| Average Diluted Shares Outstanding | 35.29M | 30.20M | 26.73M | 23.83M | 21.61M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |